Stay updated on Fianlimab & Cemiplimab Combo in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Fianlimab & Cemiplimab Combo in Melanoma Clinical Trial page.

Latest updates to the Fianlimab & Cemiplimab Combo in Melanoma Clinical Trial page
- Check5 days agoChange DetectedThe footer now shows Revision: v3.6.2, replacing the previous v3.6.0, indicating a newer site revision on the Study Record History page.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedRecruitment status updated to 'no longer looking for participants'. The record notes a new revision label v3.6.0, replacing the previous v3.5.5.SummaryDifference0.3%

- Check26 days agoChange DetectedA new revision entry v3.5.5 is added to the history, and the previous v3.5.4 entry is removed from the list.SummaryDifference0.1%

- Check48 days agoChange DetectedA new site revision, v3.5.4, was added to the history, replacing the previous revision v3.5.3 and signaling an update to the ClinicalTrials.gov interface.SummaryDifference0.1%

- Check69 days agoChange DetectedA newer record version was added, indicating administrative updates to the study’s status and associated contacts/locations. The only other textual change is an internal version/revision label for the ClinicalTrials.gov interface.SummaryDifference0.4%

- Check76 days agoChange DetectedAdded revision: v3.5.2 to the history and deleted revision: v3.5.0 from the history.SummaryDifference0.1%

Stay in the know with updates to Fianlimab & Cemiplimab Combo in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fianlimab & Cemiplimab Combo in Melanoma Clinical Trial page.